MEB 12.5% 0.9¢ medibio limited

249D to fail, page-11

  1. 62 Posts.
    lightbulb Created with Sketch. 5

    We’ve all lost money on this Rockford. Your PR role is great but it’s a little one sided and trying to talk up terrible stock doesn’t make it real. Everyone wants the company to get back on track. Mental health needs it. No one really cares about the 249D. everyone cares about the decision making. Thankfully Mr Mower knows he isn’t med tech leadership and is probably doing the best job anyone can warming the chair. The company has to announce the fda delays to be transparent and has to admit it actually has less than 60 days cash if you can be objective about it. Honesty and good decisions. Not fake Jews will get the company on the mend. 

 
watchlist Created with Sketch. Add MEB (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.